Australia's SpeeDx raises $15m from US-based Northpond
SpeeDx, an Australian developer of molecular diagnostics solutions, has raised $15 million from US-based VC firm Northpond Ventures across two tranches.
Founded in 2009, SpeeDx focuses on in vitro diagnostic tests involving molecules that bind to certain chemicals, creating radiological markers that allow for the detection of diseases in real time. Its...
More on Australasia
Latest News
Asia IPOs gone cold: India edition
A compilation of India-based IPOs - some of them private equity-backed - that have been withdrawn or appear to have fallen behind schedule
China LiDAR specialist Hesai aims for US IPO
Hesai Technology, a China-based developer of sensors used in autonomous driving, is targeting a US listing. Its investors include Lightspeed China Partners, Baidu, Bosch, and Xiaomi.
Indonesia fintech start-up iSeller gets $12m
Indonesia financial technology start-up iSeller, which helps businesses to digitise sales and operations, has raised USD 12m in Series B funding led by Intudo Ventures.
Hillhouse-backed China pet services business seeks US listing
New Ruipeng Pet Group, a China-based pet care services platform that counts Hillhouse Capital as a significant shareholder, has filed for an IPO in the US.